These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36579730)
1. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study. Lee YB; Kim S; Kim HS J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730 [No Abstract] [Full Text] [Related]
2. Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study. Han JH; Ju HJ; Kang H; Lee JH; Lee S; Bae JM Br J Dermatol; 2023 Sep; 189(4):488-490. PubMed ID: 37335952 [No Abstract] [Full Text] [Related]
3. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea'. Choi JW; Lee ES Br J Dermatol; 2020 Dec; 183(6):1149-1150. PubMed ID: 32762038 [No Abstract] [Full Text] [Related]
4. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea' - reply from the authors. Kim HS; Ahn HS Br J Dermatol; 2020 Dec; 183(6):1150-1151. PubMed ID: 32767749 [No Abstract] [Full Text] [Related]
5. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea. Kang H; Lee S Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of vitiligo and associated comorbidities in Korea. Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178 [TBL] [Abstract][Full Text] [Related]
7. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea. Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609 [TBL] [Abstract][Full Text] [Related]
8. Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study. Lim JH; Lew BL; Sim WY; Kwon SH J Am Acad Dermatol; 2022 Nov; 87(5):1196-1198. PubMed ID: 35276286 [No Abstract] [Full Text] [Related]
9. Risk for neurodegenerative disorders in Korean patients with vitiligo: A nationwide retrospective cohort study. Kim TG; Shin J; Hwang S; Lee SH; Chang Kim H; Oh SH J Am Acad Dermatol; 2019 Aug; 81(2):621-623. PubMed ID: 30654072 [No Abstract] [Full Text] [Related]
10. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea. Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331 [TBL] [Abstract][Full Text] [Related]
11. Familial Risk of Vitiligo among First-Degree Relatives and Spouses: A Population-Based Cohort Study in Korea. Kim HJ; Ahn HS; Kazmi SZ; Kang T; Kim HS; Kang MJ; Kim KB; Kim DS; Hann HJ J Invest Dermatol; 2021 Apr; 141(4):921-924.e3. PubMed ID: 32888956 [No Abstract] [Full Text] [Related]
12. All-Cause and Cause-Specific Mortality among Patients with Vitiligo: A Nationwide Population-Based Study in Korea. Ju HJ; Kang H; Han JH; Lee JH; Lee S; Bae JM J Invest Dermatol; 2024 Jan; 144(1):125-132.e3. PubMed ID: 37517513 [TBL] [Abstract][Full Text] [Related]
13. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study. Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828 [TBL] [Abstract][Full Text] [Related]
14. A Nationwide, Population-based Cohort Study on Potential Autoimmune Association of Ménière Disease to Atopy and Vitiligo. Hahn HJ; Kwak SG; Kim DK; Kim JY Sci Rep; 2019 Mar; 9(1):4406. PubMed ID: 30867466 [TBL] [Abstract][Full Text] [Related]
15. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study. Kridin K; Lyakhovitsky K; Tzur-Bitan D; Onn E; Lyakhovitsky A; Zoller L; Cohen AD Australas J Dermatol; 2023 Feb; 64(1):e65-e71. PubMed ID: 36326157 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study. Choi CW; Eun SH; Choi KH; Bae JM J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282 [TBL] [Abstract][Full Text] [Related]
17. Lack of association between vitiligo and major adverse cardiovascular events: A population-based cohort study. Wu PC; Ma SH; Wu CY; Pan TY; Chang YT; Wu CY J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e773-e775. PubMed ID: 36734285 [No Abstract] [Full Text] [Related]
18. Gaining Insight into Vitiligo Genetics through the Lens of a Large Epidemiologic Study. Okamura K; Garber M; Harris JE J Invest Dermatol; 2021 Apr; 141(4):718-721. PubMed ID: 33752810 [TBL] [Abstract][Full Text] [Related]
19. Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort. Pandya AG J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2159-2160. PubMed ID: 37877764 [No Abstract] [Full Text] [Related]
20. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. Bae JM; Lee JH; Yun JS; Han B; Han TY J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]